Preadmission Statin Treatment and Outcome in Patients Hospitalized With COVID-19.

ABSTRACT: Preadmission statin therapy is associated with improved outcome in patients hospitalized with COVID-19. Whether inhibition of inflammation and myocardial injury are in part responsible for this observation has not been studied. The aim of the present study was to relate preadmission statin usage to markers of inflammation, myocardial injury, and clinical outcome among patients with established atherosclerosis who were admitted with COVID-19. Adult patients with a diagnosis of coronary artery disease, peripheral artery disease, and/or atherosclerotic cerebrovascular disease who were hospitalized with COVID-19 between March 1, 2020 and December 31, 2020 were included. Statin use was related to the primary composite clinical outcome, death, intensive care unit admission, or thrombotic complic

SUBMITTER: Saad M 

PROVIDER: S-EPMC9194874 | biostudies-literature | 2022 Aug

REPOSITORIES: biostudies-literature